ARTICLE | Clinical News
Liprotamase: Development discontinued
February 17, 2014 8:00 AM UTC
On a conference call to discuss its 4Q13 earnings, Eli Lilly disclosed that it discontinued development of liprotamase. In 2011, FDA issued a complete response letter for liprotamase to treat EPI due ...